National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification
- PMID: 12859163
- DOI: 10.7326/0003-4819-139-2-200307150-00013
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification
Erratum in
- Ann Intern Med. 2003 Oct 7;139(7):605
Abstract
Chronic kidney disease is a worldwide public health problem with an increasing incidence and prevalence, poor outcomes, and high cost. Outcomes of chronic kidney disease include not only kidney failure but also complications of decreased kidney function and cardiovascular disease. Current evidence suggests that some of these adverse outcomes can be prevented or delayed by early detection and treatment. Unfortunately, chronic kidney disease is underdiagnosed and undertreated, in part as a result of lack of agreement on a definition and classification of its stages of progression. Recent clinical practice guidelines by the National Kidney Foundation 1) define chronic kidney disease and classify its stages, regardless of underlying cause, 2) evaluate laboratory measurements for the clinical assessment of kidney disease, 3) associate the level of kidney function with complications of chronic kidney disease, and 4) stratify the risk for loss of kidney function and development of cardiovascular disease. The guidelines were developed by using an approach based on the procedure outlined by the Agency for Healthcare Research and Quality. This paper presents the definition and five-stage classification system of chronic kidney disease and summarizes the major recommendations on early detection in adults. Recommendations include identifying persons at increased risk (those with diabetes, those with hypertension, those with a family history of chronic kidney disease, those older than 60 years of age, or those with U.S. racial or ethnic minority status), detecting kidney damage by measuring the albumin-creatinine ratio in untimed ("spot") urine specimens, and estimating the glomerular filtration rate from serum creatinine measurements by using prediction equations. Because of the high prevalence of early stages of chronic kidney disease in the general population (approximately 11% of adults), this information is particularly important for general internists and specialists.
Comment in
-
Summaries for patients. Diagnosis and evaluation of patients with chronic kidney disease: recommendations from the National Kidney Foundation.Ann Intern Med. 2003 Jul 15;139(2):I36. doi: 10.7326/0003-4819-139-2-200307150-00006. Ann Intern Med. 2003. PMID: 12859175 No abstract available.
-
Practice guidelines for chronic kidney disease.Ann Intern Med. 2004 Jun 1;140(11):933-4; author reply 934-5. doi: 10.7326/0003-4819-140-11-200406010-00024. Ann Intern Med. 2004. PMID: 15172914 No abstract available.
-
Practice guidelines for chronic kidney disease.Ann Intern Med. 2004 Jun 1;140(11):934; author reply 934-5. doi: 10.7326/0003-4819-140-11-200406010-00025. Ann Intern Med. 2004. PMID: 15172915 No abstract available.
Similar articles
-
Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease.Pharmacotherapy. 2005 Apr;25(4):491-502. doi: 10.1592/phco.25.4.491.61034. Pharmacotherapy. 2005. PMID: 15977910 Review.
-
Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers.Am Fam Physician. 2004 Sep 15;70(6):1091-7. Am Fam Physician. 2004. PMID: 15456118
-
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.Pediatrics. 2003 Jun;111(6 Pt 1):1416-21. doi: 10.1542/peds.111.6.1416. Pediatrics. 2003. PMID: 12777562
-
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).Kidney Int. 2005 Jun;67(6):2089-100. doi: 10.1111/j.1523-1755.2005.00365.x. Kidney Int. 2005. PMID: 15882252
-
Detection and evaluation of chronic kidney disease.Am Fam Physician. 2005 Nov 1;72(9):1723-32. Am Fam Physician. 2005. PMID: 16300034 Review.
Cited by
-
Non-adherence and drug-related interruptions are risk factors for delays in completion of treatment for tuberculosis.Int J Tuberc Lung Dis. 2013 Apr;17(4):486-92. doi: 10.5588/ijtld.12.0133. Epub 2013 Feb 7. Int J Tuberc Lung Dis. 2013. PMID: 23394818 Free PMC article.
-
A web-based training program to support chronic kidney disease screening by community pharmacists.Int J Clin Pharm. 2016 Oct;38(5):1080-6. doi: 10.1007/s11096-016-0330-5. Epub 2016 Jun 21. Int J Clin Pharm. 2016. PMID: 27329381
-
Association between human resources and risk of hospitalisation in end-stage renal disease outpatients receiving haemodialysis: a longitudinal cohort study using claim data during 2013-2014.BMJ Open. 2016 Aug 17;6(8):e011319. doi: 10.1136/bmjopen-2016-011319. BMJ Open. 2016. PMID: 27534988 Free PMC article.
-
Nontraditional cardiovascular biomarkers and estimation of cardiovascular risk in predialysis chronic kidney disease patients and their correlations with carotid intima media thickness.Nephrourol Mon. 2014 Nov 11;6(6):e22112. doi: 10.5812/numonthly.22112. eCollection 2014 Nov. Nephrourol Mon. 2014. PMID: 25738114 Free PMC article.
-
Preclinical evaluation of 99mTc(CO)3-aspartic-N-monoacetic acid, a renal radiotracer with pharmacokinetic properties comparable to 131I-o-iodohippurate.J Nucl Med. 2012 Aug;53(8):1277-83. doi: 10.2967/jnumed.111.102236. Epub 2012 Jun 20. J Nucl Med. 2012. PMID: 22717977 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical